BioCentury
ARTICLE | Company News

Medicis, Ansata peptide technology deal

December 14, 2004 8:00 AM UTC

Ansata (La Jolla, Calif.) granted MRX exclusive worldwide rights to develop Ansata's antimicrobial peptide technology, including preclinical compounds discovered using this technology. Ansata will rec...